Become a member



EBPMN – Biopharma in focus

By Mr Syed Ahmed, Vice President, EBPMN

As leaders in the biopharma industry in emerging economies, it is our responsibility to stay ahead of the curve and pave the way for innovation. The potential impact on patients’ lives is immense; by bringing cutting-edge treatments closer to those who need them most, we have the power to save lives and improve quality of life around the world.

Complex manufacturing requirements

By Tiago Rocca, Strategic Partnerships and BD Director, Instituto Butantan and Secretary, EBPMN.

The biopharmaceutical industry, one of the most dynamic, is continuously evolving, and an overview of 2023–2024 reveals several key trends and developments. From innovative new drugs to advancements in technology, the next few years promise to offer a lot of exciting developments.

Scroll to Top